# Short-term Intravenous Iron Isomaltose Anhydride for IDA

> **NCT03915327** · NA · NOT_YET_RECRUITING · sponsor: **West China Hospital** · enrollment: 1600 (estimated)

## Conditions studied

- Iron Deficiency Anemia

## Interventions

- **DRUG:** Intravenous iron isomaltose anhydride

## Key facts

- **NCT ID:** NCT03915327
- **Lead sponsor:** West China Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-07-05
- **Primary completion:** 2028-05-31
- **Final completion:** 2029-05-31
- **Target enrollment:** 1600 (ESTIMATED)
- **Last updated:** 2024-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03915327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03915327, "Short-term Intravenous Iron Isomaltose Anhydride for IDA". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03915327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*